Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children-Reference-Cited by-同舟云学术

Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children

Published:2012-04 Issue:2 Volume:34 Page:198-208
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Paci Angelo,Vassal Gilles,Moshous Despina,Dalle Jean-Hugues,Bleyzac Nathalie,Neven Bénédicte,Galambrun Claire,Kemmel Véronique,Abdi Zeinab D.,Broutin Sophie,Pétain Aurélie,Nguyen Laurent

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference54 articles.

1. Plasma concentration monitoring of busulfan: does it improve clinical outcome.;McCune;Clin Pharmacokinet,2000

2. Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation.;McCune;Bone Marrow Transplant,2002

3. An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease.;Bolinger;Bone Marrow Transplant,2000

4. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.;Slattery;Bone Marrow Transplant,1995

5. Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.;Slattery;Blood,1997

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2024-09-13

2. Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric Patients;Therapeutic Drug Monitoring;2024-06-14

3. Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation study;CPT: Pharmacometrics & Systems Pharmacology;2023-07-25

4. Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative Simulations;Clinical Pharmacokinetics;2023-07

5. Predicting busulfan exposure in patients undergoing hematopoietic stem cell transplantation using machine learning techniques;Expert Review of Clinical Pharmacology;2023-06-20